½ÃÀ庸°í¼­
»óǰÄÚµå
1823789

³úÁ¹Áß ÀçȰ ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2032³â)

Stroke Rehabilitation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 250 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Persistence Market Research´Â À̹ø¿¡ ¼¼°èÀÇ ³úÁ¹Áß ÀçȰ ½ÃÀå¿¡ °üÇÑ Á¾ÇÕ º¸°í¼­¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ½ÃÀå ¼ºÀå ÃËÁø¿äÀΡ¤µ¿Ç⡤±âȸ¡¤°úÁ¦ µîÀÇ Áß¿äÇÑ ½ÃÀå ¿ªÇÐÀ» öÀúÇÏ°Ô Æò°¡Çϰí, ½ÃÀå ±¸Á¶¿¡ °üÇÑ »ó¼¼ ÀλçÀÌÆ®¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀÌ Á¶»ç ¸®Æ÷Æ®´Â 2025-2032³âÀÇ ¼¼°è ³úÁ¹Áß ÀçȰ ½ÃÀåÀÇ ¿¹Ãø ¼ºÀå ±Ëµµ¸¦ ¼³¸íÇÏ´Â µ¶Á¡ µ¥ÀÌÅÍ¿Í Åë°è¸¦ °ÔÀçÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

  • ³úÁ¹Áß ÀçȰ ½ÃÀå ±Ô¸ð(2025 E) : 2¾ï 9,550¸¸ ´Þ·¯
  • ¿¹Ãø ½ÃÀå ±Ô¸ð(2032³â) : 5¾ï 4,370¸¸ ´Þ·¯
  • ¼¼°è ½ÃÀå ¼ºÀå·ü(CAGR 2025-2032) : 9.1%

³úÁ¹Áß ÀçȰ ½ÃÀå - ¸®Æ÷Æ® ¹üÀ§

³úÁ¹Áß ÀçȰÀº ³úÁ¹Áß ÈÄ È¯ÀÚ°¡ ÀÒ¾î¹ö¸° ±â´ÉÀ» ȸº¹ÇÏ°í µ¶¸³¼ºÀ» µÇã´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀçȰ °úÁ¤¿¡´Â ¹°¸®Ä¡·á, ÀÛ¾÷Ä¡·á, ¾ð¾îÄ¡·á, ½Å°æÀçȰ±â¼úÀÌ Æ÷ÇԵ˴ϴÙ. ³úÁ¹Áß ÀçȰ ½ÃÀåÀº º´¿ø, ÀçȰ¼¾ÅÍ, ¿Ü·¡ Áø·á¼Ò, Àç°¡ ¿ä¾ç ÇöÀå¿¡¼­ ȯÀÚ °³°³ÀÎÀÇ Çʿ信 µû¶ó ´Ù¾çÇÑ Ä¡·á¹ý, Àåºñ, ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ³úÁ¹Áß À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ÀçȰ ±â¼úÀÇ ¹ßÀüÀ¸·Î ÀÎÇÑ È¯ÀÚ ¿¹ÈÄ ¹× ȸº¹ È¿À² Çâ»óÀÔ´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:

¼¼°è ³úÁ¹Áß ÀçȰġ·á ½ÃÀåÀº °í·ÉÈ­¿Í °íÇ÷¾Ð, ´ç´¢º´, ºñ¸¸°ú °°Àº »ýȰ½À°ü °ü·Ã À§Çè¿äÀÎÀ¸·Î ÀÎÇÑ ³úÁ¹Áß ¹ßº´·ü Áõ°¡ µî ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ³úÁ¹Áß ÈÄ ÀçȰ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í Á¶±â °³ÀÔÀÇ Á߿伺ÀÌ ³ô¾ÆÁö¸é¼­ ÀçȰġ·á ¹× º¸Á¶±â±¸¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ·Îº¿ ÀçȰ, °¡»óÇö½Ç(VR) ±â¹Ý Ä¡·á, ³ú-ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º(BCI) ±â±â µîÀÇ ±â¼ú ¹ßÀüÀº ȯÀÚÀÇ Âü¿©µµ¸¦ ³ôÀ̰í ȸº¹ ¼Óµµ¸¦ ³ôÀ̱â À§ÇØ ½ÃÀå È®´ë¿¡ ´õ¿í ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ³úÁ¹Áß Ä¡·á ¹× ÀçȰ ¼­ºñ½º¸¦ ÃËÁøÇϱâ À§ÇÑ Á¤ºÎÀÇ ±¸»ó°ú ÇコÄÉ¾î °³Çõµµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ:

³úÁ¹Áß ÀçȰġ·á ½ÃÀåÀº À¯¸Á ¼ºÀå ÀáÀç·ÂÀ» °¡Áö°í ÀÖÁö¸¸, ƯÈ÷ ÁßÀú¼Òµæ ±¹°¡¿¡¼­ ³ôÀº Ä¡·áºñ, Á¦ÇÑÀûÀÎ »óȯ Á¤Ã¥, Á¢±Ù¼º ¹®Á¦¿Í °ü·ÃµÈ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ÷´Ü ÀçȰ±â±â³ª Ä¡·á¹ýÀº °í°¡À̱⠶§¹®¿¡ ±¸¸ÅÇϱ⠽¬¿î °¡°Ý¿¡´Â ÇѰ谡 ÀÖÀ¸¸ç, º¸±ÞÀÇ À庮ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼÷·ÃµÈ ÀçȰ Àü¹®°¡ÀÇ ºÎÁ·°ú ÀÇ·á ÀÎÇÁ¶óÀÇ Áö¿ªÀû °ÝÂ÷°¡ ÀçȰ ¼­ºñ½ºÀÇ °¡¿ë¼º°ú È¿°ú¼º¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϱâ À§Çؼ­´Â Á¤Ã¥Àû Áö¿ø, ÇÕ¸®ÀûÀÎ °¡°ÝÀÇ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÅõÀÚ, ÀÇ·á Àü¹®°¡¸¦ À§ÇÑ ±³À° ÇÁ·Î±×·¥ °­È­°¡ ÇÊ¿äÇÕ´Ï´Ù.

½ÃÀå ±âȸ:

³úÁ¹Áß ÀçȰ ½ÃÀåÀº µðÁöÅÐ Çコ, ÀçÅà ÀçȰ, AI¸¦ Ȱ¿ëÇÑ ÀçȰ ¼Ö·ç¼ÇÀÇ Çõ½ÅÀ¸·Î Å« ¼ºÀå ±âȸ¸¦ ¸ÂÀÌÇϰí ÀÖ½À´Ï´Ù. ¿ø°Ý ÀçȰ Ç÷§ÆûÀÇ µµÀÔÀ¸·Î ¿ø°Ý Ä¡·á ¼¼¼ÇÀÌ °¡´ÉÇØÁü¿¡ µû¶ó ¼­ºñ½º°¡ ÃæºÐÇÏÁö ¾ÊÀº Áö¿ªÀÇ ÀçȰ ¼­ºñ½º Á¢±Ù¼ºÀÌ È®´ëµÉ °ÍÀ¸·Î ±â´ëµË´Ï´Ù. ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×À» ÀçȰ Àåºñ¿¡ ÅëÇÕÇÏ¿© °³ÀÎÈ­µÈ Ä¡·á °èȹÀ» °­È­Çϰí ȯÀÚÀÇ ÁøÀüÀ» °¡¼ÓÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ, ¿¬±¸ ±â°ü, ÀÇ·á±â±â Á¦Á¶¾÷üÀÇ Çù·ÂÀº Çõ½ÅÀ» ÃËÁøÇÏ°í »õ·Î¿î ÀçȰ ¼Ö·ç¼Ç°ú ȯÀÚ °á°ú °³¼±À¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù. ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ÀçȰ ÇÁ·Î±×·¥ È®´ë¿Í ¹Î°ü Çù·ÂÀÇ ÃßÁøÀº ½ÃÀå È®´ë¸¦ ´õ¿í ÃËÁøÇÒ °ÍÀÔ´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

  • ¼¼°è ³úÁ¹Áß ÀçȰġ·á ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
  • ´Ù¾çÇÑ ÇコÄɾî ȯ°æ¿¡¼­ ¾î¶² Ä¡·á¹ýÀ̳ª ÀçȰ ±â¼úÀÌ °¢±¤À» ¹Þ°í Àִ°¡?
  • ±â¼úÀÇ ¹ßÀüÀº ³úÁ¹Áß ÀçȰ ½ÃÀå °æÀï ±¸µµ¸¦ ¾î¶»°Ô º¯È­½Ã۰í Àִ°¡?
  • ³úÁ¹Áß ÀçȰ ½ÃÀå¿¡ ±â¿©ÇÏ´Â ÁÖ¿ä ±â¾÷Àº ¾îµðÀ̸ç, ½ÃÀåÀÇ °ü·Ã¼ºÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» äÅÃÇϰí Àִ°¡?
  • ¼¼°è ³úÁ¹Áß ÀçȰġ·á ½ÃÀåÀÇ »õ·Î¿î µ¿Çâ°ú Àü¸ÁÀº?

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀå °³¿ä

  • ½ÃÀåÀÇ ¹üÀ§¿Í Á¤ÀÇ
  • ½ÃÀå ¿ªÇÐ
    • ÃËÁø¿äÀÎ
    • ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • ÁÖ¿ä µ¿Çâ
  • °Å½Ã°æÁ¦ ¿äÀÎ
    • ¼¼°èÀÇ ºÎ¹®º° Àü¸Á
    • ¼¼°è GDP ¼ºÀå Àü¸Á
  • COVID-19ÀÇ ¿µÇ⠺м®
  • ¿¹Ãø ¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ

Á¦3Àå ºÎ°¡°¡Ä¡ ÀλçÀÌÆ®

  • Á¦Ç° äÅà ºÐ¼®
  • Áúȯ ¿ªÇÐ-³úÁ¹Áß
  • ±ÔÁ¦ »óȲ
  • ¹ë·ùüÀÎ ºÐ¼®
  • PESTLE ºÐ¼®
  • Porter's Five Forces ºÐ¼®

Á¦4Àå °¡°Ý ºÐ¼®, 2024A

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • Á¦Ç° °¡°Ý¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ
  • Á¦Ç°º° °¡°Ý ºÐ¼®
  • Áö¿ª °¡°Ý°ú Á¦Ç° ¼±È£µµ

Á¦5Àå ¼¼°èÀÇ ³úÁ¹Áß ÀçȰ ½ÃÀå Àü¸Á

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
    • ½ÃÀå ±Ô¸ð ¿¹Ãø
    • ½ÃÀå ±Ô¸ð¿Í Àü³â´ëºñ ¼ºÀå·ü
    • Àý´ëÀû ¸ÅÃâ ±âȸ
  • ½ÃÀå ±Ô¸ð¿Í ¼ö·® ºÐ¼®°ú ¿¹Ãø
      °ú°Å ½ÃÀå ±Ô¸ð¿Í ¼ö·® ºÐ¼®, 2019-2024³â ÇöÀç ½ÃÀå ±Ô¸ð¿Í ¼ö·® ºÐ¼®°ú ¿¹Ãø, 2025-2032³â
  • ¼¼°èÀÇ ³úÁ¹Áß ÀçȰ ½ÃÀå Àü¸Á : Á¦Ç°
    • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð¿Í ¼ö·® ºÐ¼®, Á¦Ç°º°, 2019-2024³â
    • ÇöÀç ½ÃÀå ±Ô¸ð¿Í ¼ö·® ºÐ¼®°ú ¿¹Ãø, Á¦Ç°º°, 2025-2032³â
      • Àü±â Àڱرâ
      • ·Îº¿ Àڱرâ
      • ºñħ½À¼º Àڱرâ
      • ÀÎÁö Àڱرâ
      • ±âŸ
    • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Á¦Ç°
  • ¼¼°èÀÇ ³úÁ¹Áß ÀçȰ ½ÃÀå Àü¸Á : ½ºÆ®·ÎÅ© À¯Çü
    • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð¿Í ºÐ¼®, ½ºÆ®·ÎÅ© À¯Çüº°, 2019-2024³â
    • ÇöÀç ½ÃÀå ±Ô¸ð¿Í ºÐ¼®°ú ¿¹Ãø, ½ºÆ®·ÎÅ© À¯Çüº°, 2025-2032³â
      • ÇãÇ÷¼º ³úÁ¹Áß
      • ÃâÇ÷¼º ³úÁ¹Áß
      • Àϰú¼º ³úÇãÇ÷¹ßÀÛ
      • ±âŸ
    • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ½ºÆ®·ÎÅ© À¯Çü
  • ¼¼°èÀÇ ³úÁ¹Áß ÀçȰ ½ÃÀå Àü¸Á : ÃÖÁ¾»ç¿ëÀÚ
    • ¼­·Ð/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð¿Í ºÐ¼®, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2024³â
    • ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø, ÃÖÁ¾»ç¿ëÀÚº°, 2025-2032³â
      • º´¿ø
      • Àü¹® Ŭ¸®´Ð
      • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
      • Àå±â ÄÉ¾î ¼¾ÅÍ
      • ȨÄÉ¾î ¼³Á¤
      • ÀçȰ ¼¾ÅÍ
    • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚ

Á¦6Àå ¼¼°èÀÇ ³úÁ¹Áß ÀçȰ ½ÃÀå Àü¸Á : Áö¿ª

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °ú°Å ½ÃÀå ±Ô¸ð ¼ö·®À̶ó°í ºÐ¼®, Áö¿ªº°, 2019-2024³â
  • ÇöÀç ½ÃÀå ±Ô¸ð¿Í ¼ö·® ºÐ¼®°ú ¿¹Ãø, Áö¿ªº°, 2025-2032³â
    • ºÏ¹Ì
    • À¯·´
    • µ¿¾Æ½Ã¾Æ
    • ³²¾Æ½Ã¾Æ¿Í ¿À¼¼¾Æ´Ï¾Æ
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Áö¿ª

Á¦7Àå ºÏ¹ÌÀÇ ³úÁ¹Áß ÀçȰ ½ÃÀå Àü¸Á

Á¦8Àå À¯·´ÀÇ ³úÁ¹Áß ÀçȰ ½ÃÀå Àü¸Á

Á¦9Àå µ¿¾Æ½Ã¾ÆÀÇ ³úÁ¹Áß ÀçȰ ½ÃÀå Àü¸Á

Á¦10Àå ³²¾Æ½Ã¾Æ¡¤¿À¼¼¾Æ´Ï¾ÆÀÇ ³úÁ¹Áß ÀçȰ ½ÃÀå Àü¸Á

Á¦11Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ³úÁ¹Áß ÀçȰ ½ÃÀå Àü¸Á

Á¦12Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ³úÁ¹Áß ÀçȰ ½ÃÀå Àü¸Á

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â
  • ½ÃÀå ±¸Á¶
    • ½ÃÀ庰 °æÀï °ÝÈ­ ¸Ê
    • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ °³¿ä(»ó¼¼ - °³¿ä, À繫, Àü·«, ÃÖ±Ù µ¿Çâ)
    • Penumbra, Inc.
    • Saebo Inc.
    • DJO Global
    • Shenzhen XFT Medical Limited
    • Neofect
    • Siyi Intelligent Technology Co., Ltd.
    • Soterix Medical Inc.
    • Restorative Therapies
    • Zynex Medical, Inc.
    • MYOLYN
    • ACP-Accelerated Care Plus
    • Neurosoft
    • BIONIK Inc
    • EB Neuro SpA
    • Motorika Medical
    • Ottobock
    • Guangzhou Longest Science &Technology Co., Ltd.
    • Roceso Technologies Pte Ltd.
    • Brain Stimulation AB
    • Stroke Rehab
    • Motus Nova
    • MicroTransponder Inc.
    • Neurolutions, Inc

Á¦14Àå ºÎ·Ï

  • Á¶»ç ¹æ¹ý
  • Á¶»çÀÇ ÀüÁ¦
  • µÎÀÚ¾î¿Í ¾à¾î
KSA

Persistence Market Research has recently released a comprehensive report on the worldwide market for stroke rehabilitation. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global stroke rehabilitation market from 2025 to 2032.

Key Insights:

  • Stroke Rehabilitation Market Size (2025E): USD 295.5 Mn
  • Projected Market Value (2032F): USD 543.7 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 9.1%

Stroke Rehabilitation Market - Report Scope:

Stroke rehabilitation plays a crucial role in helping patients recover lost functions and regain independence after a stroke. The rehabilitation process includes physical therapy, occupational therapy, speech therapy, and neurorehabilitation technologies. The stroke rehabilitation market serves hospitals, rehabilitation centers, outpatient clinics, and homecare settings, offering a range of therapies, devices, and services tailored to individual patient needs. Market growth is driven by the rising prevalence of strokes, increasing geriatric population, and advancements in rehabilitation technology, improving patient outcomes and recovery efficiency.

Market Growth Drivers:

The global stroke rehabilitation market is propelled by several key factors, including the increasing incidence of strokes due to aging populations and lifestyle-related risk factors such as hypertension, diabetes, and obesity. Growing awareness of post-stroke rehabilitation and the importance of early intervention is driving demand for rehabilitation therapies and assistive devices. Technological advancements, such as robotic rehabilitation, virtual reality (VR)-based therapy, and brain-computer interface (BCI) devices, enhance patient engagement and accelerate recovery, further fueling market expansion. Additionally, government initiatives and healthcare reforms promoting stroke care and rehabilitation services contribute to market growth.

Market Restraints:

Despite promising growth prospects, the stroke rehabilitation market faces challenges related to high treatment costs, limited reimbursement policies, and accessibility issues, particularly in low- and middle-income countries. The high cost of advanced rehabilitation devices and therapies limits affordability, creating barriers to widespread adoption. Moreover, a shortage of skilled rehabilitation professionals and regional disparities in healthcare infrastructure impact the availability and effectiveness of rehabilitation services. Addressing these challenges requires policy support, investment in affordable solutions, and enhanced training programs for healthcare professionals.

Market Opportunities:

The stroke rehabilitation market presents significant growth opportunities driven by innovations in digital health, home-based rehabilitation, and AI-powered rehabilitation solutions. The adoption of tele-rehabilitation platforms enables remote therapy sessions, expanding access to rehabilitation services in underserved regions. The integration of artificial intelligence (AI) and machine learning in rehabilitation devices enhances personalized treatment plans and accelerates patient progress. Furthermore, collaborations between healthcare providers, research institutions, and medical device manufacturers foster innovation, leading to new rehabilitation solutions and improved patient outcomes. Expanding rehabilitation programs in emerging markets and promoting public-private partnerships further support market expansion.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the stroke rehabilitation market globally?
  • Which therapies and rehabilitation technologies are gaining traction across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the stroke rehabilitation market?
  • Who are the key players contributing to the stroke rehabilitation market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global stroke rehabilitation market?

Competitive Intelligence and Business Strategy:

Leading players in the global stroke rehabilitation market, including Medtronic, Bionik Laboratories, Hocoma AG, and Ekso Bionics, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced rehabilitation solutions, including robotic exoskeletons, neuromodulation devices, and AI-driven therapy systems, catering to diverse patient needs. Collaborations with healthcare providers, rehabilitation centers, and academic institutions facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the evolving stroke rehabilitation landscape.

Key Companies Profiled:

  • Medtronic
  • Bionik Laboratories
  • Hocoma AG
  • Ekso Bionics
  • Bioxtreme Robotics Rehabilitation
  • ReWalk Robotics
  • Abbott Laboratories
  • Neofect
  • Tyromotion GmbH
  • DJO Global

Stroke Rehabilitation Market Research Segmentation:

By Therapy Type:

  • Physical Therapy
  • Occupational Therapy
  • Speech and Language Therapy
  • Cognitive Therapy

By Technology:

  • Robotic Rehabilitation Devices
  • Neurorehabilitation Devices
  • Wearable Devices
  • Brain-Computer Interface (BCI) Systems
  • Virtual Reality (VR)-Based Rehabilitation

By End-User:

  • Hospitals
  • Rehabilitation Centers
  • Outpatient Clinics
  • Homecare Settings

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Stroke Rehabilitation Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Disease Epidemiology - Stroke
  • 3.3. Regulatory Landscape
  • 3.4. Value Chain Analysis
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Price Analysis, 2024A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product
  • 4.4. Regional Prices and Product Preferences

5. Global Stroke Rehabilitation Market Outlook

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Mn) and Volume (Units) Analysis, 2019-2024
    • 5.2.2. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, 2025-2032
  • 5.3. Global Stroke Rehabilitation Market Outlook: Product
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2024
    • 5.3.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
      • 5.3.3.1. Electrical Stimulators
      • 5.3.3.2. Robotic Stimulators
      • 5.3.3.3. Non-Invasive Stimulators
      • 5.3.3.4. Cognitive Stimulators
      • 5.3.3.5. Others
    • 5.3.4. Market Attractiveness Analysis: Product
  • 5.4. Global Stroke Rehabilitation Market Outlook: Stroke Type
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Mn), By Stroke Type, 2019-2024
    • 5.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Stroke Type, 2025-2032
      • 5.4.3.1. Ischemic Stroke
      • 5.4.3.2. Hemorrhagic Stroke
      • 5.4.3.3. Transient Ischemic Attack
      • 5.4.3.4. Others
    • 5.4.4. Market Attractiveness Analysis: Stroke Type
  • 5.5. Global Stroke Rehabilitation Market Outlook: End User
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
    • 5.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
      • 5.5.3.1. Hospitals
      • 5.5.3.2. Specialty Clinics
      • 5.5.3.3. Ambulatory Surgical Centers
      • 5.5.3.4. Long Term Care Centers
      • 5.5.3.5. Homecare Settings
      • 5.5.3.6. Rehabilitation Centers
    • 5.5.4. Market Attractiveness Analysis: End User

6. Global Stroke Rehabilitation Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2019-2024
  • 6.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Stroke Rehabilitation Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Stroke Type
    • 7.2.4. By End User
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 7.4.1. Electrical Stimulators
    • 7.4.2. Robotic Stimulators
    • 7.4.3. Non-Invasive Stimulators
    • 7.4.4. Cognitive Stimulators
    • 7.4.5. Others
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Stroke Type, 2025-2032
    • 7.5.1. Ischemic Stroke
    • 7.5.2. Hemorrhagic Stroke
    • 7.5.3. Transient Ischemic Attack
    • 7.5.4. Others
  • 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 7.6.1. Hospitals
    • 7.6.2. Specialty Clinics
    • 7.6.3. Ambulatory Surgical Centers
    • 7.6.4. Long Term Care Centers
    • 7.6.5. Homecare Settings
    • 7.6.6. Rehabilitation Centers
  • 7.7. Market Attractiveness Analysis

8. Europe Stroke Rehabilitation Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Stroke Type
    • 8.2.4. By End User
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 8.4.1. Electrical Stimulators
    • 8.4.2. Robotic Stimulators
    • 8.4.3. Non-Invasive Stimulators
    • 8.4.4. Cognitive Stimulators
    • 8.4.5. Others
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Stroke Type, 2025-2032
    • 8.5.1. Ischemic Stroke
    • 8.5.2. Hemorrhagic Stroke
    • 8.5.3. Transient Ischemic Attack
    • 8.5.4. Others
  • 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 8.6.1. Hospitals
    • 8.6.2. Specialty Clinics
    • 8.6.3. Ambulatory Surgical Centers
    • 8.6.4. Long Term Care Centers
    • 8.6.5. Homecare Settings
    • 8.6.6. Rehabilitation Centers
  • 8.7. Market Attractiveness Analysis

9. East Asia Stroke Rehabilitation Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Stroke Type
    • 9.2.4. By End User
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 9.4.1. Electrical Stimulators
    • 9.4.2. Robotic Stimulators
    • 9.4.3. Non-Invasive Stimulators
    • 9.4.4. Cognitive Stimulators
    • 9.4.5. Others
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Stroke Type, 2025-2032
    • 9.5.1. Ischemic Stroke
    • 9.5.2. Hemorrhagic Stroke
    • 9.5.3. Transient Ischemic Attack
    • 9.5.4. Others
  • 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 9.6.1. Hospitals
    • 9.6.2. Specialty Clinics
    • 9.6.3. Ambulatory Surgical Centers
    • 9.6.4. Long Term Care Centers
    • 9.6.5. Homecare Settings
    • 9.6.6. Rehabilitation Centers
  • 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Stroke Rehabilitation Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Stroke Type
    • 10.2.4. By End User
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 10.4.1. Electrical Stimulators
    • 10.4.2. Robotic Stimulators
    • 10.4.3. Non-Invasive Stimulators
    • 10.4.4. Cognitive Stimulators
    • 10.4.5. Others
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Stroke Type, 2025-2032
    • 10.5.1. Ischemic Stroke
    • 10.5.2. Hemorrhagic Stroke
    • 10.5.3. Transient Ischemic Attack
    • 10.5.4. Others
  • 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 10.6.1. Hospitals
    • 10.6.2. Specialty Clinics
    • 10.6.3. Ambulatory Surgical Centers
    • 10.6.4. Long Term Care Centers
    • 10.6.5. Homecare Settings
    • 10.6.6. Rehabilitation Centers
  • 10.7. Market Attractiveness Analysis

11. Latin America Stroke Rehabilitation Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Stroke Type
    • 11.2.4. By End User
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 11.4.1. Electrical Stimulators
    • 11.4.2. Robotic Stimulators
    • 11.4.3. Non-Invasive Stimulators
    • 11.4.4. Cognitive Stimulators
    • 11.4.5. Others
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Stroke Type, 2025-2032
    • 11.5.1. Ischemic Stroke
    • 11.5.2. Hemorrhagic Stroke
    • 11.5.3. Transient Ischemic Attack
    • 11.5.4. Others
  • 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 11.6.1. Hospitals
    • 11.6.2. Specialty Clinics
    • 11.6.3. Ambulatory Surgical Centers
    • 11.6.4. Long Term Care Centers
    • 11.6.5. Homecare Settings
    • 11.6.6. Rehabilitation Centers
  • 11.7. Market Attractiveness Analysis

12. Middle East & Africa Stroke Rehabilitation Market Outlook

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 12.2.1. By Country
    • 12.2.2. By Product
    • 12.2.3. By Stroke Type
    • 12.2.4. By End User
  • 12.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 12.4.1. Electrical Stimulators
    • 12.4.2. Robotic Stimulators
    • 12.4.3. Non-Invasive Stimulators
    • 12.4.4. Cognitive Stimulators
    • 12.4.5. Others
  • 12.5. Current Market Size (US$ Mn) Analysis and Forecast, By Stroke Type, 2025-2032
    • 12.5.1. Ischemic Stroke
    • 12.5.2. Hemorrhagic Stroke
    • 12.5.3. Transient Ischemic Attack
    • 12.5.4. Others
  • 12.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 12.6.1. Hospitals
    • 12.6.2. Specialty Clinics
    • 12.6.3. Ambulatory Surgical Centers
    • 12.6.4. Long Term Care Centers
    • 12.6.5. Homecare Settings
    • 12.6.6. Rehabilitation Centers
  • 12.7. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Penumbra, Inc.
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Products
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Saebo Inc.
    • 13.3.3. DJO Global
    • 13.3.4. Shenzhen XFT Medical Limited
    • 13.3.5. Neofect
    • 13.3.6. Siyi Intelligent Technology Co., Ltd.
    • 13.3.7. Soterix Medical Inc.
    • 13.3.8. Restorative Therapies
    • 13.3.9. Zynex Medical, Inc.
    • 13.3.10. MYOLYN
    • 13.3.11. ACP- Accelerated Care Plus
    • 13.3.12. Neurosoft
    • 13.3.13. BIONIK Inc
    • 13.3.14. EB Neuro S.p.A.
    • 13.3.15. Motorika Medical
    • 13.3.16. Ottobock
    • 13.3.17. Guangzhou Longest Science & Technology Co., Ltd.
    • 13.3.18. Roceso Technologies Pte Ltd.
    • 13.3.19. Brain Stimulation AB
    • 13.3.20. Stroke Rehab
    • 13.3.21. Motus Nova
    • 13.3.22. MicroTransponder Inc.
    • 13.3.23. Neurolutions, Inc

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦